Mohammed Zayed

In 2020, Mohammed joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) at the University of Oxford as a Clinical Research Fellow working on large randomised clinical trials.

These include: ORION-4 (a cardiovascular outcome trial of the cholesterol-lowering drug; inclisiran); LENS (a major streamlined study which is investigating the effect of the cholesterol-lowering drug, fenofibrate, on the progression of diabetic eye disease); and, RECOVERY (an international clinical trial aims to identify treatments that may be beneficial for people hospitalised with suspected or confirmed COVID-19) . He is also a part-time GP and a GMC PLAB examiner. 

Mohammed graduated from Alexandria Medical School in Egypt in 2010 where he was awarded his MBChB degree with Honours. He then moved to the UK and completed his foundation training in 2012. He gained experience working in Ophthalmology and as a medical tutor in the Royal Hallamshire Hospital and the University of Sheffield between 2012 and 2014. He completed his GP training and obtained his MRCGP in Leeds in 2017 and was awarded the title of Visiting Lecturer at the University of Leeds. 

He joined Swansea University Medical School in 2018 as an Academic GP and was awarded his MSc degree in Clinical Medicine with Distinction in 2021.